Lipocalin 2 expression is associated with aggressive features of endometrial cancer

Monica Mannelqvist,Ingunn Stefansson,Elisabeth Wik,Kanthida Kusonmano,Maria B. Ræder,Anne Margrete Øyan,Karl-Henning Kalland,Marsha A. Moses,Helga B. Salvesen,Lars A. Akslen

Lipocalin 2 expression is associated with aggressive features of endometrial cancer

2012

Monica Mannelqvist
Ingunn Stefansson
Elisabeth Wik
Kanthida Kusonmano
Maria B. Ræder
Anne Margrete Øyan
Karl-Henning Kalland
Marsha A. Moses
Helga B. Salvesen
Lars A. Akslen

Background Increased expression of lipocalin 2 (LCN2) has been observed in several cancers. The aim of the present study was to investigate LCN2 in endometrial cancer in relation to clinico-pathologic phenotype, angiogenesis, markers of epithelial-mesenchymal transition (EMT), and patient survival.

Keywords:

Cancer research
Pathology
Epithelial–mesenchymal transition
Angiogenesis
Lipocalin
Stem cell
Medicine
Surgical oncology
Endometrial cancer
Phenotype
Immunohistochemistry

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations